Martin H. Steinberg, MD
Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Hematology & Medical Oncology

MD, Tufts University School of Medicine
AB, Cornell University



Martin H Steinberg, MD, is a hematologist/internist whose clinical and research focus has been on disorders of the red blood cell with special emphasis on sickle cell disease. He has published 450 articles and 3 textbooks on the science and clinical features of sickle cell disease and related disorders. A graduate of Cornell University and Tufts University School of Medicine he completed post-graduate training in New York and Boston. He conducts basic, translational and clinical studies devoted to understanding the pathophysiology and genetic basis of sickle cell phenotypic heterogeneity. He modeled the HbF concentration among red blood cells showing that only patients with very high HbF levels were likely to have major benefit, therefor setting a standard for HbF induction therapies. He identified cis- and trans-acting elements that help explain the high HbF levels of Saudi patients from the Eastern Province whose sickle hemoglobin gene is associated with the Arab-Indian haplotype. Using candidate gene, genome-wide association studies and next-generation sequencing to understand the genetic determinants of sickle cell disease heterogeneity, Dr. Steinberg and his coworkers modeled disease severity and selected subphenotypes of disease to discover hitherto unsuspected genetic associations. He has also reimagined the pathophysiologic features of sickle cell anemia, establishing with his collaborators a new widely accepted paradigm that the pathophysiology of sickle cell disease is a combination of both sickle vasoocclusion and intravascular hemolysis that has important prognostic and therapeutic implications. He also reported the first of a new class of hemoglobin disorders, the thalassemic hemoglobinopathies, wherein a single exonic mutation causes both a variant hemoglobin but also phenotype of thalassemia because of hemoglobin hyper-instability and catabolism.

Diversity, Equity, Inclusion and Accessibility

Dr. Steinberg champions equal opportunity and treatment for everybody.

Professor
Boston University Chobanian & Avedisian School of Medicine
Pathology & Laboratory Medicine


Professor
Boston University Chobanian & Avedisian School of Medicine
Pediatrics


Member
Boston University
Center for Regenerative Medicine


Member
Boston University
Center of Excellence in Sickle Cell Disease


Member
Boston University
Evans Center for Interdisciplinary Biomedical Research


Member
Boston University
Genome Science Institute


Graduate Faculty (Primary Mentor of Grad Students)
Boston University Chobanian & Avedisian School of Medicine, Graduate Medical Sciences




Research Training in Blood Diseases and Resources
06/01/2014 - 05/31/2021 (Multi-PI)
PI: Martin H. Steinberg, MD
NIH/National Heart, Lung, and Blood Institute
5T32HL007501-36

Mechanisms of cis-acting HbF regulation in sickle cell anemia
04/01/2017 - 03/31/2021 (Multi-PI)
PI: Martin H. Steinberg, MD
Boston Medical Center Corporation NIH NHLBI
5R01HL133350-04

Severity Index for Sickle Cell anemia in the Eastern Province of Saudi Arabia
01/01/2013 - 12/31/2018 (PI)
King Faisal University


A prototype diagnostic for cellular fetal hemoglobin in sickle cell disease
08/01/2016 - 01/31/2018 (Multi-PI)
PI: Martin H. Steinberg, MD
MyoSyntax Corporation NIH NHLBI
1R43HL134529-01

Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells
07/05/2011 - 06/30/2017 (Multi-PI)
PI: Martin H. Steinberg, MD
NIH/National Heart, Lung, and Blood Institute
5U01HL107443-05

Genetic Basis of Fetal Hemoglobin in Saudi Sickle Cell Anemia
01/02/2012 - 12/31/2016 (PI)
University of Dammam Saudi Arabia


Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells
07/05/2011 - 06/30/2016 (PI)
NIH/National Heart, Lung, and Blood Institute
1U01HL107443-01

A prototype diagnostic for cellular fetal hemoglobin in sickle cell disease
08/15/2014 - 01/30/2016 (Subcontract PI)
MyoSyntax Corporation NIH NHLBI
1R43HL124679-01

Gene Polymorphism in Chronic Sickle Cell Lung Disease
01/01/2005 - 12/31/2009 (Dept Sponsor)
NIH/National Heart, Lung, and Blood Institute
5 K23 HL79003 05

Genetic Modulation of Sickle Cell Anemia
05/01/2006 - 04/30/2009 (PI)
NIH/Fogarty International Center
5 R03 TW07189 03

Showing 10 of 13 results. Show All Results

BTRP Admin Core
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
5U54 HL070819-08

BTRP Clinical Trials
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
5U54 HL070819-07

BTRP Research Scholar
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
5U54 HL070819-07

BTRP Subcontracts
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
5U54 HL070819-08

BTRP Training Supplement
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
2U54 HL070819-06

CSSC Admin Core
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
2U54 HL070819-06

CSSC Butyrate
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
2U54 HL070819-06

CSSC Clinical Core
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
2U54 HL070819-06

CSSC Geno-Pheno Core Lab
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
2U54 HL070819-06

CSSC Patient Service Core
04/01/2008 - 03/31/2012 (PI)
NIH-NHLBI
2U54 HL070819-06

Showing 10 of 18 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs
2020 Mechanisms of cis-acting HbF regulation in sickle cell anemia 5R01HL133350-04 11
2019 Mechanisms of cis-acting HbF regulation in sickle cell anemia 5R01HL133350-03 11
2018 Mechanisms of cis-acting HbF regulation in sickle cell anemia 5R01HL133350-02 11
2018 Research Training in Blood Diseases and Resources 5T32HL007501-36 119
2017 Mechanisms of cis-acting HbF regulation in sickle cell anemia 1R01HL133350-01A1 11
2017 Research Training in Blood Diseases and Resources 5T32HL007501-35 119
2016 A prototype diagnostic for cellular fetal hemoglobin in sickle cell disease 1R43HL134529-01
2016 Research Training in Blood Diseases and Resources 5T32HL007501-34 119
2015 Globin Gene Expression in Sickle Cell Genotype-Specific iPS cells 5U01HL107443-05 16
2015 Research Training in Blood Diseases and Resources 5T32HL007501-33 119
Showing 10 of 73 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Heitzer AM, Rashkin SR, Trpchevska A, Longoria JN, Rampersaud E, Olufadi Y, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G, Takemoto CM, Hankins JS. Catechol-O-methyltransferase gene (COMT) is associated with neurocognitive functioning in patients with sickle cell disease. Curr Res Transl Med. 2023 Nov 21; 72(2):103433. PMID: 38244277
     
  2. Steinberg MH, Gladwin MT. "Severity" in adult sickle cell disease. Am J Hematol. 2023 Oct; 98(10):1508-1511. PMID: 37449407
     
  3. Ribeil JA, Pollock G, Frangoul H, Steinberg MH. An integrated therapeutic approach to sickle cell disease management beyond infancy. Am J Hematol. 2023 Jul; 98(7):1087-1096.View Related Profiles. PMID: 37170801
     
  4. Sebastiani P, Steinberg MH. Fetal hemoglobin per erythrocyte (HbF/F-cell) after gene therapy for sickle cell anemia. Am J Hematol. 2023 Feb; 98(2):E32-E34.View Related Profiles. PMID: 36420999
     
  5. Cyrus C, Vatte C, Al-Nafie A, Chathoth S, Akhtar MS, Darwish M, Almohazey D, AlDubayan SH, Steinberg MH, Al-Ali A. miRNA Expression Associated with HbF in Saudi Sickle Cell Anemia. Medicina (Kaunas). 2022 Oct 17; 58(10). PMID: 36295630; PMCID: PMC9611475; DOI: 10.3390/medicina58101470;
     
  6. Minniti C, Brugnara C, Steinberg MH. HbSC disease: A time for progress. Am J Hematol. 2022 Nov; 97(11):1390-1393. PMID: 36073655
     
  7. Steinberg MH. World Sickle Cell Day 2022: Progress & prospects. Indian J Med Res. 2022 Jul; 156(1):10-13. PMID: 35946231; PMCID: PMC9903380; DOI: 10.4103/ijmr.ijmr_1049_22;
     
  8. Steinberg MH. Targeting fetal hemoglobin expression to treat ß hemoglobinopathies. Expert Opin Ther Targets. 2022 Apr; 26(4):347-359. PMID: 35418266
     
  9. Steinberg MH. Fetal hemoglobin in ß hemoglobinopathies: Is enough too much? Am J Hematol. 2022 Jun 01; 97(6):676-678. PMID: 35253929
     
  10. Heitzer AM, Longoria J, Rampersaud E, Rashkin SR, Estepp JH, Okhomina VI, Wang WC, Raches D, Potter B, Steinberg MH, King AA, Kang G, Hankins JS. Fetal hemoglobin modulates neurocognitive performance in sickle cell anemia?,??. Curr Res Transl Med. 2022 Jul; 70(3):103335. PMID: 35303690; PMCID: PMC9086114; DOI: 10.1016/j.retram.2022.103335;
     
Showing 10 of 362 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 328 publications over 44 distinct years, with a maximum of 15 publications in 2011

YearPublications
19803
19817
19828
19838
19846
19853
19865
19876
19883
19891
19902
199114
19923
19935
19947
19956
19968
19977
19983
19997
20005
20019
20022
20036
20047
200510
200612
20079
200813
200912
20108
201115
201213
201312
201413
201511
20169
201714
20186
20196
20207
20214
202210
20233
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

fetal hemoglobin
genomics
sickle cell
SNPs

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Research / Scholarly Mentor
Contact for Mentoring:

72 East Concord Street
Boston MA 02118
Google Map


Steinberg's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department